Gilead sticks to DEI, thinking it is immune to competition who can run business more efficiently after dropping DEI. This is a typical pharma arrogance syndrome, with business not run efficiently, under excuse of specific nature of healthcare. The cost is passed on patients, healthcare system and overall on all premium and tax payers, pharma being one of the leaches. Time to have more DOGE-like bodies to reform the whole system. Sounds impossible? Would result in 20-30% reduction of employment and deportations.
Gilead should stop tinkering with DEI and bring on board capable people with deep and diversified experience, forming more posts like Internal Advisors or Internal Consultants.
Some companies do this.
Gilead has a chance now to improve its position as well as re-evaluate approaches to cell therapy. Preferential treatment of
certain groups of employees must end.
Gilead has one of the highest revenues per employee, so it can afford mismanagement, bad strategies, dei, Kite drag, and other wasteful policies. Who pays for this? Patients, taxpayers and all thru insurance premiums.
Gilead has announced more than 100 person layoff coming, this time from the HQ location.
Streamlining ahead of a new administration, or as usual, a result of internal chaos and turmoil?
More layoffs would come in 2025.
layoff of 72, a small number comparing to company size, but be one of these.
Another proof how incompetent the pharma management is. Strategy, what strategy? Firstly they create a hype, hire many and then, oops!
